Kilpatrick Townsend’s Silicon Valley-based start-up team advised the founders of Editas Medicine in the biotech start-up’s $43 million Series A Financing. In a trend setting transaction, venture firms Polaris Partners, Third Rock Ventures, Flagship Ventures and the Partners Innovation Fund invited five of the most prominent research scientists in the field of genomics from MIT, Harvard, the Howard Hughes Medical Institute and the University of California in Berkeley to form a company which they would fund. The money invested will fund the collaborative research and development by this world-class team of scientists as they seek to revolutionize the treatment of genetic disorders by developing a simple, precise and inexpensive method of ‘editing out’ abnormalities in genes in human cells.

Experience Center

Match our Experience to Your Needs

View All Case Studies

Experience Highlights

Construction litigation for a general contractor
Represented the general contractor in disputes surrounding the construction of a 70,000 square foot casino. During construction, our more
Patent prosecution and counseling services to Adobe Systems Incorporated
Provides patent procurement and counseling services to Adobe Systems Incorporated, one of the largest and most diversified software companies in the more
Race discrimination class action for one of the largest U.S. forest product manufacturers
Represented one of the largest U.S. forest products manufacturers in a suit brought against our client in Alabama Federal court by the EEOC on behalf more
Real estate finance, construction loan for a consortium
Advising a consortium on construction financing, procured from international bank(s) for a landmark development in the city centre of Stockholm. more